Bandaram Pharma Packtech
BANDARAMPHARMAPACKTECHLTD NSE
Bandaram Pharma Packtech
Healthcare ServicesNSE: BANDARAMPHARMAPACKTECHLTD BSE: 524602 Healthcare Service Provider
Key Fundamentals
MicrocapHealthcare Service ProviderHealthcare ServicesMarket Cap
₹38.60 Cr
Volatility
Moderate
P/E Ratio
32.6
EBITDA
₹2.90 Cr
Return on Equity
6.28%
Debt to Equity
0.89
Book Value
₹14.9
EPS
₹0.86
52W High
₹49.7
52W Low
₹17.25
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Company is expected to give good quarter
Weaknesses
4- Company has a low return on equity of 6.00% over last 3 years.
- Company might be capitalizing the interest cost
- Company has high debtors of 182 days.
- Promoter holding has decreased over last 3 years: -12.3%
Growth Rate
Revenue Growth
69.6% higher than
3Y
Net Income Growth
-56% lower than
3Y
Cash Flow Change
-19.37% higher than
3Y
ROE
-0.16% lower than
3Y
ROCE
-13.55% lower than
3Y
EBITDA Margin (Avg.)
-41.42% higher than
3Y
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.87 | 7.36 | 7.36 | 13.43 | 11.37 | 7.11 | 10 | 8.49 | 8.1 | 13.72 | 14.84 | 26.26 | 23.95 |
| Expenses | 5.34 | 6.89 | 6.89 | 12.7 | 10.83 | 6.02 | 9.34 | 7.95 | 7.47 | 13.27 | 13.84 | 25.44 | 22.4 |
| Operating Profit | 0.53 | 0.47 | 0.47 | 0.73 | 0.54 | 1.09 | 0.66 | 0.54 | 0.63 | 0.45 | 1 | 0.82 | 1.55 |
| OPM % | 9.03% | 6.39% | 6.39% | 5.44% | 4.75% | 15.33% | 6.6% | 6.36% | 7.78% | 3.28% | 6.74% | 3.12% | 6.47% |
| Other Income | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0.09 | 0 | 0.01 | 0 | 0.01 | 0 |
| Interest | 0.28 | 0.17 | 0.17 | 0.32 | 0.21 | 0.26 | 0.24 | -0.1 | 0.46 | 0.25 | 0.33 | 0.46 | 0.42 |
| Depreciation | 0.18 | 0.18 | 0.18 | 0.19 | 0.15 | 0.15 | 0.15 | 0.53 | 0.13 | 0.14 | 0.14 | 0.25 | 0.2 |
| PBT | 0.07 | 0.12 | 0.12 | 0.25 | 0.18 | 0.68 | 0.27 | 0.2 | 0.04 | 0.07 | 0.53 | 0.12 | 0.93 |
| Tax % | 0% | 0% | 0% | 24% | 0% | 0% | 103.7% | 25% | 25% | 28.57% | 33.96% | 25% | 25.81% |
| Net Profit | 0.07 | 0.12 | 0.12 | 0.19 | 0.18 | 0.67 | -0.02 | 0.15 | 0.02 | 0.06 | 0.35 | 0.09 | 0.68 |
| EPS in Rs | 0.06 | 0.1 | 0.1 | 0.16 | 0.15 | 0.56 | -0.01 | 0.12 | 0.02 | 0.02 | 0.11 | 0.05 | 0.38 |
Profit & Loss
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Sales | 0 | 18.73 | 34.08 | 36.96 | 62.92 | 78.77 |
| Expenses | 0.01 | 17.58 | 31.26 | 34.13 | 60.02 | 74.95 |
| Operating Profit | -0.01 | 1.15 | 2.82 | 2.83 | 2.9 | 3.82 |
| OPM % | — | 6.14% | 8.27% | 7.66% | 4.61% | 4.85% |
| Other Income | 0 | 0.19 | 0.03 | 0.09 | 0.02 | 0.02 |
| Interest | 0 | 0.43 | 0.93 | 0.99 | 1.51 | 1.46 |
| Depreciation | 0 | 0.59 | 0.73 | 0.61 | 0.97 | 0.73 |
| PBT | -0.01 | 0.32 | 1.19 | 1.32 | 0.44 | 1.65 |
| Tax % | 0% | 21.88% | 20.17% | 24.24% | -2.27% | — |
| Net Profit | -0.01 | 0.26 | 0.95 | 0.99 | 0.45 | 1.18 |
| EPS in Rs | -0.01 | 0.12 | 0.79 | 0.82 | 0.25 | 0.56 |
| Div. Payout % | 0% | 21.43% | 12.63% | 12.12% | 0% | — |
Balance Sheet
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 7.06 | 3 | 12 | 12 | 17.97 |
| Reserves | -0.06 | 0.08 | 0.28 | 0.65 | 8.81 |
| Borrowings | 0 | 14.2 | 12.2 | 17.15 | 23.94 |
| Other Liabilities | 0.48 | 2.9 | 7.58 | 9.12 | 25.14 |
| Total Liabilities | 7.48 | 20.18 | 32.06 | 38.92 | 75.86 |
| Fixed Assets | 2.87 | 5.03 | 4.48 | 3.95 | 15.22 |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 2.09 | 0 | 1.4 | 1.4 | 0 |
| Other Assets | 2.52 | 15.15 | 26.18 | 33.57 | 60.64 |
| Total Assets | 7.48 | 20.18 | 32.06 | 38.92 | 75.86 |
Cash Flow
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | — | -1.1 | -4.13 | -4.93 | -4.92 |
| Investing | — | -5.3 | -1.58 | -0.08 | 0 |
| Financing | — | 4.47 | 5.59 | 5.09 | 5.53 |
| Net Cash Flow | — | -1.93 | -0.11 | 0.08 | 0.6 |
| Free Cash Flow | — | -3.89 | -4.31 | -5.01 | -4.92 |
| CFO/OP | — | -96 | -139 | -163 | -170 |
Ratios
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | — | 129 | 156 | 185 | 182 |
| Inventory Days | — | — | — | — | 87.71 |
| Days Payable | — | — | — | — | 110 |
| Cash Conversion Cycle | — | 129 | 156 | 185 | 159 |
| Working Capital Days | — | 147 | 148 | 165 | 127 |
| ROCE % | — | 5.69% | 9.1% | 7.67% | 4.42% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Bandaram Pharma Packtech insights
57 extracted metrics + investor summaries across FY00–FY26.
Documents
1
Clarification sought from Bandaram Pharma Packtech Ltd
6 Jul - Exchange has sought clarification from Bandaram Pharma Packtech Ltd on July 6, 2026 with reference to significant movement in price, in order to ensure that … 6 Jul - Exchange has sought clarification from Bandaram Pharma Packtech Ltd on July 6, 2026 with reference to significant movement in price, in order to ensure that …
2
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
30 Apr - Bandaram Pharma Packtech says it is not a large corporate; FY2026-27 initial disclosure not applicable. 30 Apr - Bandaram Pharma Packtech says it is not a large corporate; FY2026-27 initial disclosure not applicable.
3
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
30 Apr - Bandaram Pharma Packtech confirms it is not a Large Corporate for FY2025-26; no debt borrowing reported. 30 Apr - Bandaram Pharma Packtech confirms it is not a Large Corporate for FY2025-26; no debt borrowing reported.
4
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
30 Apr - Bandaram Pharma Packtech says it is not a large corporate; FY2026-27 initial disclosure not applicable. 30 Apr - Bandaram Pharma Packtech says it is not a large corporate; FY2026-27 initial disclosure not applicable.
5
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
30 Apr - Bandaram Pharma Packtech confirms it is not a Large Corporate for FY2025-26; no debt borrowing reported. 30 Apr - Bandaram Pharma Packtech confirms it is not a Large Corporate for FY2025-26; no debt borrowing reported.
Frequently Asked Questions about Bandaram Pharma Packtech
What does Bandaram Pharma Packtech Ltd do?
Incorporated in 2022, Bandaram Pharma Packtech Ltd deals in procurement and supply of recycled paper[1]
Where is Bandaram Pharma Packtech Ltd (524602) listed?
Bandaram Pharma Packtech Ltd trades as BANDARAMPHARMAPACKTECHLTD on the NSE and under code 524602 on the BSE.
Which sector does Bandaram Pharma Packtech Ltd belong to?
Bandaram Pharma Packtech Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the market capitalisation of Bandaram Pharma Packtech Ltd?
Bandaram Pharma Packtech Ltd has a market capitalisation of ₹38.6 Cr, which places it in the Small Cap band.
What is the PE ratio of Bandaram Pharma Packtech Ltd?
Bandaram Pharma Packtech Ltd trades at a PE ratio of 32.60, on earnings per share of ₹0.86, against a book value of ₹14.9 per share.
What is the 52-week high and low of Bandaram Pharma Packtech Ltd?
Over the last 52 weeks Bandaram Pharma Packtech Ltd has traded between ₹17.25 and ₹49.7.
Does Bandaram Pharma Packtech Ltd pay dividends?
Bandaram Pharma Packtech Ltd has a dividend yield of 0.47%.
What is the Return on Equity (ROE) of Bandaram Pharma Packtech Ltd?
Bandaram Pharma Packtech Ltd reported a return on equity of 6.28%. Its debt-to-equity ratio is 0.89.
Company Information
Incorporated in 2022, Bandaram Pharma Packtech Ltd deals in procurement and supply of recycled paper[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524602.md for Bandaram Pharma Packtech Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.